Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study finds chemotherapy helps women with localized ovarian cancer

27.09.2004


A new study finds chemotherapy improves survival and reduces the risk of recurrence in women with stage I ovarian cancer (cancer that has not spread beyond the ovary). But it remains unclear which patients would most benefit from adjuvant chemotherapy and what the optimal treatment regimen would entail. The findings come from an analytical review of data from 13 randomized control trials (RCTs), which will be published in the November 1, 2004 issue of CANCER, a peer-reviewed journal of the American Cancer Society. A free abstract of this article will be available via the CANCER News Room upon online publication.

About one quarter of all ovarian cancers are caught while confined to the ovaries, when five-year survival is 85 percent. But the therapeutic benefit of adjuvant chemotherapy remains controversial. All physicians agree that surgery that includes staging is critical to survival. Some doctors may prefer not to offer chemotherapy for their patients, since eight in ten are adequately treated by surgery alone. They could argue that giving all stage I patients chemotherapy would lead to unnecessary adverse events with no survival benefit for the majority of patients.

Given the controversy, Laurie Elit, M.D., of the Juravinski Regional Cancer Centre in Ontario, Canada and her colleagues conducted a meta-analysis of RCT data published since 1965.



First, adequate surgical staging was a prognostic factor for cancer survival. Most studies in this review did not show adequate staging of patients. Second, patients who received any adjuvant chemotherapy had a lower risk of death (relative risk, 0.74) and recurrence (relative risk, 0.70) than those who did not receive chemotherapy. However, insufficient data and conflicting data exist regarding the optimal regimens (e.g., three versus six cycles), optimal doses, and the role of adjuvant radiotherapy.

The authors strongly recommend that women receive appropriate surgical staging: "women with optimally staged stage I ovarian cancer, a pathology review by a gynecologic pathologist, and good prognostic factors (stage Ia or stage Ib grade 1) have an excellent prognosis without adjuvant chemotherapy." They add: "There is evidence adjuvant chemotherapy improves survival and decreases recurrence rates. What remains to be defined is the population of stage I patients who would most benefit from adjuvant therapy, the optimal chemotherapy regimen, and the dose and duration of treatment."

David Greenberg | EurekAlert!
Further information:
http://www.interscience.wiley.com/cancer-newsroom
http://www.wiley.com

More articles from Studies and Analyses:

nachricht The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung

nachricht A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>